Silverfin false false 31/01/2026 01/02/2025 31/01/2026 KTR Clark 01/12/2021 DA Sinclair 02/08/2017 D A Sinclair 27 October 2026 The principal activity of the company is the distribution of ophthalmic surgical devices and procedure packs. SC211557 2026-01-31 SC211557 bus:Director1 2026-01-31 SC211557 bus:Director2 2026-01-31 SC211557 2025-01-31 SC211557 core:CurrentFinancialInstruments 2026-01-31 SC211557 core:CurrentFinancialInstruments 2025-01-31 SC211557 core:ShareCapital 2026-01-31 SC211557 core:ShareCapital 2025-01-31 SC211557 core:SharePremium 2026-01-31 SC211557 core:SharePremium 2025-01-31 SC211557 core:RetainedEarningsAccumulatedLosses 2026-01-31 SC211557 core:RetainedEarningsAccumulatedLosses 2025-01-31 SC211557 core:LandBuildings 2025-01-31 SC211557 core:OtherPropertyPlantEquipment 2025-01-31 SC211557 core:LandBuildings 2026-01-31 SC211557 core:OtherPropertyPlantEquipment 2026-01-31 SC211557 bus:OrdinaryShareClass1 2026-01-31 SC211557 2025-02-01 2026-01-31 SC211557 bus:FilletedAccounts 2025-02-01 2026-01-31 SC211557 bus:SmallEntities 2025-02-01 2026-01-31 SC211557 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 SC211557 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 SC211557 bus:Director1 2025-02-01 2026-01-31 SC211557 bus:Director2 2025-02-01 2026-01-31 SC211557 bus:Director3 2025-02-01 2026-01-31 SC211557 core:LandBuildings core:TopRangeValue 2025-02-01 2026-01-31 SC211557 core:OtherPropertyPlantEquipment core:TopRangeValue 2025-02-01 2026-01-31 SC211557 2024-02-01 2025-01-31 SC211557 core:LandBuildings 2025-02-01 2026-01-31 SC211557 core:OtherPropertyPlantEquipment 2025-02-01 2026-01-31 SC211557 bus:OrdinaryShareClass1 2025-02-01 2026-01-31 SC211557 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 SC211557 1 2025-02-01 2026-01-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC211557 (Scotland)

EYESUPPLY LIMITED

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 JANUARY 2026
PAGES FOR FILING WITH THE REGISTRAR

EYESUPPLY LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 JANUARY 2026

Contents

EYESUPPLY LIMITED

COMPANY INFORMATION

FOR THE FINANCIAL YEAR ENDED 31 JANUARY 2026
EYESUPPLY LIMITED

COMPANY INFORMATION (continued)

FOR THE FINANCIAL YEAR ENDED 31 JANUARY 2026
DIRECTORS KTR Clark
DA Sinclair
REGISTERED OFFICE Unit 55 Imex Business Centre
Dryden Road
Bilston Glen Industrial Estate
EH20 9LZ
United Kingdom
COMPANY NUMBER SC211557 (Scotland)
ACCOUNTANT Shaw Gibbs Limited
Salatin House
19 Cedar Road
Sutton
SM2 5DA
EYESUPPLY LIMITED

BALANCE SHEET

AS AT 31 JANUARY 2026
EYESUPPLY LIMITED

BALANCE SHEET (continued)

AS AT 31 JANUARY 2026
Note 2026 2025
£ £
Fixed assets
Tangible assets 3 1,138 344
1,138 344
Current assets
Stocks 4 169,548 243,123
Debtors 5 36,653 45,221
Cash at bank and in hand 6 80,574 113,437
286,775 401,781
Creditors: amounts falling due within one year 7 ( 56,247) ( 127,365)
Net current assets 230,528 274,416
Total assets less current liabilities 231,666 274,760
Net assets 231,666 274,760
Capital and reserves
Called-up share capital 8 10,000 10,000
Share premium account 57,550 57,550
Profit and loss account 164,116 207,210
Total shareholders' funds 231,666 274,760

For the financial year ending 31 January 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Eyesupply Limited (registered number: SC211557) were approved and authorised for issue by the Board of Directors on 27 October 2026. They were signed on its behalf by:

D A Sinclair
Director
EYESUPPLY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 JANUARY 2026
EYESUPPLY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 JANUARY 2026
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Eyesupply Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is Unit 55 Imex Business Centre, Dryden Road, Bilston Glen Industrial Estate, EH20 9LZ, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the sale of goods is recognised when the goods are physically delivered to the customer.

Taxation

Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Land and buildings 10 years straight line
Plant and machinery etc. 4 years straight line

Depreciation methods, useful lives and residual values are reviewed at each balance sheet date. The selection of these residual values and estimated lives requires the exercise of judgement. The directors are required to assess whether there is an indication of impairment to the carrying value of assets. In making that assessment, judgements are made in estimating value in use. The directors consider that the individual carrying values of assets are supportable by their value in use.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2026 2025
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Land and buildings Plant and machinery etc. Total
£ £ £
Cost
At 01 February 2025 8,330 10,626 18,956
Additions 0 1,590 1,590
At 31 January 2026 8,330 12,216 20,546
Accumulated depreciation
At 01 February 2025 8,330 10,282 18,612
Charge for the financial year 0 796 796
At 31 January 2026 8,330 11,078 19,408
Net book value
At 31 January 2026 0 1,138 1,138
At 31 January 2025 0 344 344

4. Stocks

2026 2025
£ £
Stocks 169,548 243,123

5. Debtors

2026 2025
£ £
Trade debtors 25,990 40,879
Prepayments 6,290 4,342
Corporation tax 4,373 0
36,653 45,221

6. Cash and cash equivalents

2026 2025
£ £
Cash at bank and in hand 80,574 113,437

7. Creditors: amounts falling due within one year

2026 2025
£ £
Trade creditors 42,952 106,822
Accruals 1,989 2,453
Taxation and social security 8,313 15,098
Other creditors 2,993 2,992
56,247 127,365

8. Called-up share capital

2026 2025
£ £
Allotted, called-up and fully-paid
10,000 Ordinary shares of £ 1.00 each 10,000 10,000

9. Events after the Balance Sheet date

There have been no events after the balance sheet date affecting the Company since the financial year.